Autopsy report · NCT02791256
A Study of Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6
Cause of deathNo reason given
Life of this trial
- Registered 11 years after it had already started.
- Ran for about 3 years before it stopped.
- 23 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Hoffmann-La Roche
- Sponsor type
- Industry
- Conditions
- Hepatitis C, Chronic
- Interventions
- Ribavirin; peginterferon alfa-2a
- Participants
- 23
- Sites
- 21
- Countries
- Belgium
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.